Reaction Details |
| Report a problem with these data |
Target | Monoacylglycerol lipase ABHD6 |
---|
Ligand | BDBM50556532 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_2056358 (CHEMBL4711359) |
---|
IC50 | >10000±n/a nM |
---|
Citation | Arena, C; Gado, F; Di Cesare Mannelli, L; Cervetto, C; Carpi, S; Reynoso-Moreno, I; Polini, B; Vallini, E; Chicca, S; Lucarini, E; Bertini, S; D'Andrea, F; Digiacomo, M; Poli, G; Tuccinardi, T; Macchia, M; Gertsch, J; Marcoli, M; Nieri, P; Ghelardini, C; Chicca, A; Manera, C The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis. Eur J Med Chem208:0 (2020) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Monoacylglycerol lipase ABHD6 |
---|
Name: | Monoacylglycerol lipase ABHD6 |
Synonyms: | 2-arachidonoylglycerol hydrolase | ABHD6 | ABHD6_HUMAN | Abhydrolase domain-containing protein 6 | Monoacylglycerol lipase ABHD6 |
Type: | PROTEIN |
Mol. Mass.: | 38341.83 |
Organism: | Homo sapiens (Human) |
Description: | ChEMBL_105457 |
Residue: | 337 |
Sequence: | MDLDVVNMFVIAGGTLAIPILAFVASFLLWPSALIRIYYWYWRRTLGMQVRYVHHEDYQF
CYSFRGRPGHKPSILMLHGFSAHKDMWLSVVKFLPKNLHLVCVDMPGHEGTTRSSLDDLS
IDGQVKRIHQFVECLKLNKKPFHLVGTSMGGQVAGVYAAYYPSDVSSLCLVCPAGLQYST
DNQFVQRLKELQGSAAVEKIPLIPSTPEEMSEMLQLCSYVRFKVPQQILQGLVDVRIPHN
NFYRKLFLEIVSEKSRYSLHQNMDKIKVPTQIIWGKQDQVLDVSGADMLAKSIANCQVEL
LENCGHSVVMERPRKTAKLIIDFLASVHNTDNNKKLD
|
|
|
BDBM50556532 |
---|
n/a |
---|
Name | BDBM50556532 |
Synonyms: | CHEMBL4753891 |
Type | Small organic molecule |
Emp. Form. | C21H24BrFN2O2 |
Mol. Mass. | 435.33 |
SMILES | Cc1c(Br)cc(C(=O)NC2CCCCCC2)c(=O)n1Cc1ccc(F)cc1 |
Structure |
|